Your browser doesn't support javascript.
loading
Beta-cell specific Insr deletion promotes insulin hypersecretion and improves glucose tolerance prior to global insulin resistance.
Skovsø, Søs; Panzhinskiy, Evgeniy; Kolic, Jelena; Cen, Haoning Howard; Dionne, Derek A; Dai, Xiao-Qing; Sharma, Rohit B; Elghazi, Lynda; Ellis, Cara E; Faulkner, Katharine; Marcil, Stephanie A M; Overby, Peter; Noursadeghi, Nilou; Hutchinson, Daria; Hu, Xiaoke; Li, Hong; Modi, Honey; Wildi, Jennifer S; Botezelli, J Diego; Noh, Hye Lim; Suk, Sujin; Gablaski, Brian; Bautista, Austin; Kim, Ryekjang; Cras-Méneur, Corentin; Flibotte, Stephane; Sinha, Sunita; Luciani, Dan S; Nislow, Corey; Rideout, Elizabeth J; Cytrynbaum, Eric N; Kim, Jason K; Bernal-Mizrachi, Ernesto; Alonso, Laura C; MacDonald, Patrick E; Johnson, James D.
Affiliation
  • Skovsø S; Diabetes Research Group, Life Sciences Institute, and Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Panzhinskiy E; Diabetes Research Group, Life Sciences Institute, and Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Kolic J; Diabetes Research Group, Life Sciences Institute, and Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Cen HH; Diabetes Research Group, Life Sciences Institute, and Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Dionne DA; Diabetes Research Group, Life Sciences Institute, and Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Dai XQ; Alberta Diabetes Institute and Department of Pharmacology, University of Alberta, Edmonton, Canada.
  • Sharma RB; Division of Endocrinology, Diabetes and Metabolism and the Weill Center for Metabolic Health, Weill Cornell Medicine, New York, NY, USA.
  • Elghazi L; Department of Ophthalmology and Visual Sciences, University of Michigan Kellogg Eye Center, Ann Arbor, MI, USA.
  • Ellis CE; Diabetes Research Group, Life Sciences Institute, and Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Faulkner K; Department of Mathematics, University of British Columbia, Vancouver, BC, Canada.
  • Marcil SAM; Diabetes Research Group, Life Sciences Institute, and Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Overby P; Diabetes Research Group, Life Sciences Institute, and Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Noursadeghi N; Diabetes Research Group, Life Sciences Institute, and Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Hutchinson D; Diabetes Research Group, Life Sciences Institute, and Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Hu X; Diabetes Research Group, Life Sciences Institute, and Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Li H; Diabetes Research Group, Life Sciences Institute, and Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Modi H; Diabetes Research Group, Life Sciences Institute, and Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Wildi JS; Diabetes Research Group, Life Sciences Institute, and Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Botezelli JD; Diabetes Research Group, Life Sciences Institute, and Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Noh HL; Program in Molecular Medicine University of Massachusetts Medical School, Worcester, MA, USA.
  • Suk S; Charles River Laboratories, Shrewsbury, MA, USA.
  • Gablaski B; Program in Molecular Medicine University of Massachusetts Medical School, Worcester, MA, USA.
  • Bautista A; Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA.
  • Kim R; Charles River Laboratories, Shrewsbury, MA, USA.
  • Cras-Méneur C; Alberta Diabetes Institute and Department of Pharmacology, University of Alberta, Edmonton, Canada.
  • Flibotte S; Alberta Diabetes Institute and Department of Pharmacology, University of Alberta, Edmonton, Canada.
  • Sinha S; Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, MI, USA.
  • Luciani DS; UBC Life Sciences Institute Bioinformatics Facility, University of British Columbia, Vancouver, BC, Canada.
  • Nislow C; UBC Sequencing and Bioinformatics Consortium, Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Rideout EJ; BC Children's Hospital Research Institute, Department of Surgery, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Cytrynbaum EN; UBC Sequencing and Bioinformatics Consortium, Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Kim JK; Diabetes Research Group, Life Sciences Institute, and Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Bernal-Mizrachi E; Department of Mathematics, University of British Columbia, Vancouver, BC, Canada.
  • Alonso LC; Program in Molecular Medicine University of Massachusetts Medical School, Worcester, MA, USA.
  • MacDonald PE; Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA.
  • Johnson JD; Division of Endocrinology, Diabetes and Metabolism, University of Miami Miller School of Medicine and Miami VA Health Care System, Miami, FL, USA.
Nat Commun ; 13(1): 735, 2022 02 08.
Article in En | MEDLINE | ID: mdl-35136059
ABSTRACT
Insulin receptor (Insr) protein is present at higher levels in pancreatic ß-cells than in most other tissues, but the consequences of ß-cell insulin resistance remain enigmatic. Here, we use an Ins1cre knock-in allele to delete Insr specifically in ß-cells of both female and male mice. We compare experimental mice to Ins1cre-containing littermate controls at multiple ages and on multiple diets. RNA-seq of purified recombined ß-cells reveals transcriptomic consequences of Insr loss, which differ between female and male mice. Action potential and calcium oscillation frequencies are increased in Insr knockout ß-cells from female, but not male mice, whereas only male ßInsrKO islets have reduced ATP-coupled oxygen consumption rate and reduced expression of genes involved in ATP synthesis. Female ßInsrKO and ßInsrHET mice exhibit elevated insulin release in ex vivo perifusion experiments, during hyperglycemic clamps, and following i.p. glucose challenge. Deletion of Insr does not alter ß-cell area up to 9 months of age, nor does it impair hyperglycemia-induced proliferation. Based on our data, we adapt a mathematical model to include ß-cell insulin resistance, which predicts that ß-cell Insr knockout improves glucose tolerance depending on the degree of whole-body insulin resistance. Indeed, glucose tolerance is significantly improved in female ßInsrKO and ßInsrHET mice compared to controls at 9, 21 and 39 weeks, and also in insulin-sensitive 4-week old males. We observe no improved glucose tolerance in older male mice or in high fat diet-fed mice, corroborating the prediction that global insulin resistance obscures the effects of ß-cell specific insulin resistance. The propensity for hyperinsulinemia is associated with mildly reduced fasting glucose and increased body weight. We further validate our main in vivo findings using an Ins1-CreERT transgenic line and find that male mice have improved glucose tolerance 4 weeks after tamoxifen-mediated Insr deletion. Collectively, our data show that ß-cell insulin resistance in the form of reduced ß-cell Insr contributes to hyperinsulinemia in the context of glucose stimulation, thereby improving glucose homeostasis in otherwise insulin sensitive sex, dietary and age contexts.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Insulin Resistance / Receptor, Insulin / Diabetes Mellitus, Type 2 / Insulin-Secreting Cells / Hyperinsulinism Type of study: Prognostic_studies Limits: Animals / Female / Humans / Male Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2022 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Insulin Resistance / Receptor, Insulin / Diabetes Mellitus, Type 2 / Insulin-Secreting Cells / Hyperinsulinism Type of study: Prognostic_studies Limits: Animals / Female / Humans / Male Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2022 Document type: Article Affiliation country:
...